BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 18632752)

  • 1. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
    Chan DW; Liu VW; Tsao GS; Yao KM; Furukawa T; Chan KK; Ngan HY
    Carcinogenesis; 2008 Sep; 29(9):1742-50. PubMed ID: 18632752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
    Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
    J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R; Nardinocchi L; Pistritto G; D'Orazi G
    Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
    Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
    Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK.
    Small GW; Somasundaram S; Moore DT; Shi YY; Orlowski RZ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):861-9. PubMed ID: 14557375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway.
    Chen L; Liu L; Yin J; Luo Y; Huang S
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1284-95. PubMed ID: 19038359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E suppresses telomerase activity in ovarian cancer cells.
    Bermudez Y; Ahmadi S; Lowell NE; Kruk PA
    Cancer Detect Prev; 2007; 31(2):119-28. PubMed ID: 17335992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress.
    Nguyen A; Chang AC; Reddel RR
    Oncogene; 2009 May; 28(18):1982-92. PubMed ID: 19347030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells.
    Wang J; Zhou JY; Wu GS
    Cancer Res; 2007 Dec; 67(24):11933-41. PubMed ID: 18089824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-X(L) is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells.
    Dodier P; Piché A
    Gynecol Oncol; 2006 Feb; 100(2):254-63. PubMed ID: 16188300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide anions and hydrogen peroxide inhibit proliferation of activated rat stellate cells and induce different modes of cell death.
    Dunning S; Hannivoort RA; de Boer JF; Buist-Homan M; Faber KN; Moshage H
    Liver Int; 2009 Jul; 29(6):922-32. PubMed ID: 19386027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
    Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
    Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
    Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies directed against L1-CAM synergize with Genistein in inhibiting growth and survival pathways in SKOV3ip human ovarian cancer cells.
    Novak-Hofer I; Cohrs S; Grünberg J; Friedli A; Schlatter MC; Pfeifer M; Altevogt P; Schubiger PA
    Cancer Lett; 2008 Mar; 261(2):193-204. PubMed ID: 18155830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells.
    Lee S; Yoon S; Kim DH
    Gynecol Oncol; 2007 Feb; 104(2):338-44. PubMed ID: 17023032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
    Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.
    Huang J; Che MI; Huang YT; Shyu MK; Huang YM; Wu YM; Lin WC; Huang PH; Liang JT; Lee PH; Huang MC
    Carcinogenesis; 2009 Aug; 30(8):1452-8. PubMed ID: 19520792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.